x
Filter:
Filters applied
- IDF Diabetes Atlas
- Cho, NHRemove Cho, NH filter
- Linnenkamp, URemove Linnenkamp, U filter
- Guariguata, LRemove Guariguata, L filter
IDF Diabetes Atlas
3 Results
- Research Article
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Diabetes Research and Clinical PracticeVol. 128p40–50Published online: March 31, 2017- K. Ogurtsova
- J.D. da Rocha Fernandes
- Y. Huang
- U. Linnenkamp
- L. Guariguata
- N.H. Cho
- and others
Cited in Scopus: 2288Diabetes mellitus describes a group of metabolic disorders characterised by increased blood glucose concentration. People living with diabetes have a higher risk of morbidity and mortality than the general population. The global prevalence of diabetes in adults has been increasing over recent decades. In 1964, it was estimated that 30 million people had diabetes [15]. Less than 40 years later, the WHO estimated that there were 171 million people living with diabetes [51]. The International Diabetes Federation (IDF) estimated the global prevalence to be 151 million in 2000 [28], 194 million in 2003 [27], 246 million in 2006 [26], 285 million in 2009 [25], 366 million in 2011 [24], and 382 million in 2013 [23]. - IDF Diabetes Atlas
Global estimates of the prevalence of hyperglycaemia in pregnancy
Diabetes Research and Clinical PracticeVol. 103Issue 2p176–185Published online: December 3, 2013- L. Guariguata
- U. Linnenkamp
- J. Beagley
- D.R. Whiting
- N.H. Cho
Cited in Scopus: 381We estimated the number of live births worldwide and by IDF Region who developed hyperglycaemia in pregnancy in 2013, including total diabetes in pregnancy (known and previously undiagnosed diabetes) and gestational diabetes. - IDF Diabetes Atlas
The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy
Diabetes Research and Clinical PracticeVol. 103Issue 2p186–196Published online: December 3, 2013- U. Linnenkamp
- L. Guariguata
- J. Beagley
- D.R. Whiting
- N.H. Cho
Cited in Scopus: 36Hyperglycaemia is one of the most prevalent metabolic disorders occurring during pregnancy. Limited data are available on the global prevalence of hyperglycaemia in pregnancy. The International Diabetes Federation (IDF) has developed a methodology for generating estimates of the prevalence of hyperglycaemia in pregnancy, including hyperglycaemia first detected in pregnancy and live births to women with known diabetes, among women of childbearing age (20–49 years).